R&D investment behavior of US pharmaceutical firms

J 2017

R&D investment behavior of US pharmaceutical firms

JIRÁSEK, Michal

Základní údaje

Originální název

R&D investment behavior of US pharmaceutical firms

Autoři

JIRÁSEK, Michal (203 Česká republika, garant, domácí)

Vydání

International Journal of Innovation Science, EMERALD GROUP PUBLISHING LTD, 2017, 1757-2223

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

50600 5.6 Political science

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Kód RIV

RIV/00216224:14560/17:00096812

Organizační jednotka

Ekonomicko-správní fakulta

DOI

http://dx.doi.org/10.1108/IJIS-08-2016-0030

UT WoS

000412571600007

Klíčová slova anglicky

Innovation management; R&D investment; Behavioral theory of the firm; US pharmaceutical firms

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 12. 1. 2024 13:20, Mgr. Pavlína Kurková

Anotace

V originále

Purpose – The behavioral theory of the firm (BTOF) has been used to explain the research and development (R&D) investment behavior of firms in numerous multi industry studies. However, their partially contradictory results point to the possible need for a single industry perspective that would reduce heterogeneity of business trends, models and other characteristics. This study aims to test this theoretical assumption within the challenging context of the US pharmaceutical industry. Design/methodology/approach – The research uses data from 20 firms, which number among the largest in the US pharmaceutical industry, over the period 2002-2014. These data are analyzed using fixed- and random-effect panel models. Findings – The findings generally support the need for a thorough understanding of the industry under study and its specific characteristics. The firms analyzed in this research behave slightly differently from theoretical assumptions, and it is argued that this is caused by industry specific factors. Moreover, the use of two separate aspiration measures – for historical and social aspirations – is supported as it provides more in-depth insight into the firms’ behavior.

Návaznosti

MUNI/A/0909/2015, interní kód MU

Název: Inovační schopnost jako východisko pro měření inovační výkonnosti organizací

Investor: Masarykova univerzita, Inovační schopnost jako východisko pro měření inovační výkonnosti organizací, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty

Citovat

JIRÁSEK, Michal. R&D investment behavior of US pharmaceutical firms. International Journal of Innovation Science. EMERALD GROUP PUBLISHING LTD, 2017, roč. 9, č. 2, s. 205-219. ISSN 1757-2223. Dostupné z: https://dx.doi.org/10.1108/IJIS-08-2016-0030.

@article{1381807,
   author = {Jirásek, Michal},
   article_number = {2},
   doi = {http://dx.doi.org/10.1108/IJIS-08-2016-0030},
   keywords = {Innovation management; R&D investment; Behavioral theory of the firm; US pharmaceutical firms},
   language = {eng},
   issn = {1757-2223},
   journal = {International Journal of Innovation Science},
   title = {R&D investment behavior of US pharmaceutical firms},
   url = {https://www.emerald.com/insight/content/doi/10.1108/IJIS-08-2016-0030/full/html},
   volume = {9},
   year = {2017}
}

TY  - JOUR
ID  - 1381807
AU  - Jirásek, Michal
PY  - 2017
TI  - R&D investment behavior of US pharmaceutical firms
JF  - International Journal of Innovation Science
VL  - 9
IS  - 2
SP  - 205-219
EP  - 205-219
PB  - EMERALD GROUP PUBLISHING LTD
SN  - 17572223
KW  - Innovation management
KW  - R&D investment
KW  - Behavioral theory of the firm
KW  - US pharmaceutical firms
UR  - https://www.emerald.com/insight/content/doi/10.1108/IJIS-08-2016-0030/full/html
N2  - Purpose – The behavioral theory of the firm (BTOF) has been used to explain the research and development (R&D) investment behavior of firms in numerous multi industry studies. However, their partially contradictory results point to the possible need for a single industry perspective that would reduce heterogeneity of business trends, models and other characteristics. This study aims to test this theoretical assumption within the challenging context of the US pharmaceutical industry. Design/methodology/approach – The research uses data from 20 firms, which number among the largest in the US pharmaceutical industry, over the period 2002-2014. These data are analyzed using fixed- and random-effect panel models. Findings – The findings generally support the need for a thorough understanding of the industry under study and its specific characteristics. The firms analyzed in this research behave slightly differently from theoretical assumptions, and it is argued that this is caused by industry specific factors. Moreover, the use of two separate aspiration measures – for historical and social aspirations – is supported as it provides more in-depth insight into the firms’ behavior.
ER  -

JIRÁSEK, Michal. R\&{}D investment behavior of US pharmaceutical firms. \textit{International Journal of Innovation Science}. EMERALD GROUP PUBLISHING LTD, 2017, roč.~9, č.~2, s.~205-219. ISSN~1757-2223. Dostupné z: https://dx.doi.org/10.1108/IJIS-08-2016-0030.

Podrobný výpis o publikaci